Nature is a British weekly scientific journal founded and based in London, England. As a multidisciplinary publication, Nature features peer-reviewed research from a variety of academic disciplines, mainly in science and technology. It has core editorial offices across the United States, continental Europe, and Asia under the international scientific publishing company Springer Nature. Nature was one of the world's most cited scientific journals by the Science Edition of the 2022 Journal Citation Reports, making it one of the world's most-read and most prestigious academic journals. As of 2012, it claimed an online readership of about three million unique readers per month.
PLOS is a nonprofit publisher of open-access journals in science, technology, and medicine and other scientific literature, under an open-content license. It was founded in 2000 and launched its first journal, PLOS Biology, in October 2003.
BioMed Central (BMC) is a United Kingdom-based, for-profit scientific open access publisher that produces over 250 scientific journals. All its journals are published online only. BioMed Central describes itself as the first and largest open access science publisher. It was founded in 2000 and has been owned by Springer, now Springer Nature, since 2008.
The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science.
Randy Wayne Schekman is an American cell biologist at the University of California, Berkeley, former editor-in-chief of Proceedings of the National Academy of Sciences and former editor of Annual Review of Cell and Developmental Biology. In 2011, he was announced as the editor of eLife, a new high-profile open-access journal published by the Howard Hughes Medical Institute, the Max Planck Society and the Wellcome Trust launching in 2012. He was elected to the National Academy of Sciences in 1992. Schekman shared the 2013 Nobel Prize for Physiology or Medicine with James Rothman and Thomas C. Südhof for their ground-breaking work on cell membrane vesicle trafficking.
Nature Reviews Molecular Cell Biology is a monthly peer-reviewed review journal published by Nature Portfolio. It was established in October 2000 and covers all aspects of molecular and cell biology. The editor-in-chief is Kim Baumann.
Cell is a peer-reviewed scientific journal publishing research papers across a broad range of disciplines within the life sciences. Areas covered include molecular biology, cell biology, systems biology, stem cells, developmental biology, genetics and genomics, proteomics, cancer research, immunology, neuroscience, structural biology, microbiology, virology, physiology, biophysics, and computational biology. The journal was established in 1974 by Benjamin Lewin and is published twice monthly by Cell Press, owned by Elsevier.
The Annual Review of Cell and Developmental Biology is a peer-reviewed scientific journal published by Annual Reviews since 1985. It releases an annual volume of review articles relevant to the fields of cell biology and developmental biology. Its editor has been Ruth Lehmann since 2018; as of 2023, its impact factor is 11.3. As of 2023, Annual Review of Cell and Developmental Biology is being published as open access, under the Subscribe to Open model.
Cell Press is an all-science publisher of over 50 scientific journals across the life, physical, earth, and health sciences, both independently and in partnership with scientific societies. Cell Press was founded and is currently based in Cambridge, MA, and has offices across the United States, Europe, and Asia under its parent company Elsevier.
Nature Structural & Molecular Biology is a monthly peer-reviewed scientific journal publishing research articles, reviews, news, and commentaries in structural and molecular biology, with an emphasis on papers that further a "functional and mechanistic understanding of how molecular components in a biological process work together".
The Journal of Cell Biology is a peer-reviewed scientific journal published by Rockefeller University Press.
Oncogene is a peer-reviewed scientific journal published under the Nature Portfolio addressing cancer cell genetics and the structure and function of oncogenes. The journal has editorial office in London, England under the publishing company Springer Nature. The journal was established in 1987. An open access online-only sister journal, Oncogenesis, was established in 2012 by Douglas R. Green, who was then Oncogene's editor-in-chief.
Autophagy is a monthly peer-reviewed scientific journal covering all aspects of cell autophagy. It is published by Taylor & Francis and the editor-in-chief is Daniel J. Klionsky.
Nature Communications is a peer-reviewed, open access, scientific journal published by Nature Portfolio since 2010. It is a multidisciplinary journal that covers the natural sciences, including physics, chemistry, earth sciences, medicine, and biology. The journal has editorial offices in London, Berlin, New York City, and Shanghai.
Scientific Reports is a peer-reviewed open-access scientific mega journal published by Nature Portfolio, covering all areas of the natural sciences. The journal was established in 2011. The journal states that their aim is to assess solely the scientific validity of a submitted paper, rather than its perceived importance, significance, or impact.
Frontiers Media SA is a publisher of peer-reviewed, open access, scientific journals currently active in science, technology, and medicine. It was founded in 2007 by Kamila and Henry Markram. Frontiers is based in Lausanne, Switzerland, with offices in the United Kingdom, Spain, and China. In 2022, Frontiers employed more than 1,400 people, across 14 countries. All Frontiers journals are published under a Creative Commons Attribution License.
The San Francisco Declaration on Research Assessment (DORA) is a statement that denounces the practice of correlating the journal impact factor to the merits of a specific scientist's contributions. Also according to this statement, this practice creates biases and inaccuracies when appraising scientific research. It also states that the impact factor is not to be used as a substitute "measure of the quality of individual research articles, or in hiring, promotion, or funding decisions".
Aging is a bimonthly peer-reviewed open access bio-medical journal covering research on all aspects of gerontology. The journal was established in 2009 and is published by Impact Journals. The editors-in-chief are Jan Vijg, David Andrew Sinclair, Vera Gorbunova, Judith Campisi, Mikhail V. Blagosklonny.
B. Brett Finlay, is a Canadian microbiologist well known for his contributions to understanding how microbes cause disease in people and developing new tools for fighting infections, as well as the role the microbiota plays in human health and disease. Science.ca describes him as one of the world's foremost experts on the molecular understanding of the ways bacteria infect their hosts. He also led the SARS Accelerated Vaccine Initiative (SAVI) and developed vaccines to SARS and a bovine vaccine to E. coli O157:H7. His current research interests focus on pathogenic E. coli and Salmonella pathogenicity, and the role of the microbiota in infections, asthma, and malnutrition. He is currently the UBC Peter Wall Distinguished Professor and a Professor in the Michael Smith Laboratories, Microbiology and Immunology, and Biochemistry and Molecular Biology, and Co-director and Senior Fellow for the CIFAR Humans and Microbes program. He is also co-author of the book Let Them Eat Dirt: Saving Your Child from an Oversanitized World and The Whole-Body Microbiome: How to Harness Microbes - Inside and Out - For Lifelong Health. Finlay is the author of over 500 publications in peer-reviewed journals and served as editor of several professional publications for many years.
The Annual Review of Cancer Biology is a peer-reviewed academic journal that publishes review articles about oncology. It published its first volume in 2017, making it the 47th journal published by the nonprofit Annual Reviews. Founded by Tyler Jacks and Charles L. Sawyers, it is currently edited by Laura Attardi and Scott A. Armstrong. It is content is broadly focused on cancer cell biology, tumorigenesis and cancer progression, and translational cancer science. As of 2020, Annual Review of Cancer Biology has been published open access under the Subscribe to Open (S2O) publishing model.
